News & Updates

In patients with uncontrolled, moderate-to-severe asthma, tezepelumab reduced mucus plugging, which was also tied to improvements in lung function parameters, according to an exploratory post hoc analysis of the CASCADE* trial presented at ERS 2022.

Antibiotics cannot be withheld in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for acute moderate exacerbations, suggests findings from the ABACOPD study presented at ERS 2022. However, in one subgroup, it appeared antibiotics can be ruled out.

Patients with obstructive sleep apnoea (OSA) who had the longest nocturnal hypoxaemia episodes have a twofold risk of developing venous thromboembolic events (VTE) in a study dubbed as the first to investigate the association between OSA and the incidence of unprovoked VTE.

In the treatment of patients with pulmonary hypertension (PH) with fibrotic interstitial lung disease (ILD), a higher dose of inhaled treprostinil or getting at least nine breaths four times daily increases the likelihood of achieving clinical improvement and preventing clinical worsening, according to a study.

Conventional airway clearance is still the most used treatment among all the available physiotherapy management techniques for patients in the intensive care unit (ICU), according to a Singapore study.